Niagen Bioscience Inc (NAGE)

Operating Cash Flow Growth

-71.95%

TTM · Period ending:

NAGE logo

NAGE Operating Cash Flow Growth

Year-over-year change vs the same period a year earlier

Latest reported-71.95%
NAGE TTM Cash from Operations YoY % (-2691.76% → -71.95%)
High-resolution chart · PNG

NAGE operating cash flow growth history

Trailing twelve months (TTM). Each value covers four complete reported quarters.

Niagen Bioscience Inc Operating Cash Flow Growth — Trailing twelve months (TTM)
Period endingOperating Cash Flow Growth
-71.9532%
-77.5245%
11.5204%
412.7665%
1,871.2825%
326.342%
70.1419%
-32.0033%
-46.3074%
190.4464%
147.1387%
131.1454%
109.1536%
80.3205%
37.516%
-2.6931%
-27.8573%
-140.6899%
-127.9528%
-70.9135%
-13.0455%
52.3085%
48.1384%
55.009%
32.5%
-13.2469%
2.2432%
-27.7703%
-51.8373%
-45.2993%
-113.2604%
-234.2388%
-168.1622%
-14,914.6158%
-233.8552%
-46.8296%
-19.7738%
97.9275%
-39.1001%
-164.8412%
-307.4053%
-149.9691%
18.1858%
63.0412%
70.0266%
61.6356%
33.9376%
-39.1541%
2.2341%
25.356%
61.402%
73.3566%
66.1622%
31.4704%
-146.8928%
-228.0186%
-406.0352%
-249.1563%
-54.0016%
-98.9507%
-59.7157%
-13,531.5326%
-571.8168%
-121.7497%
7.7911%
101.452%
63.1246%
10.8448%
-4,997.8252%
-2,691.7626%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.